These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 33268783

  • 1. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
    Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J, Chen F, Xi S, Chen Z.
    Cell Death Dis; 2020 Dec 02; 11(12):1032. PubMed ID: 33268783
    [Abstract] [Full Text] [Related]

  • 2. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M, Niu W, Zhang X, Hu S, Niu C.
    Oncogene; 2020 Nov 02; 39(45):6879-6892. PubMed ID: 32978519
    [Abstract] [Full Text] [Related]

  • 3. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y, Ma X, Wang Y, Li G.
    Biomed Pharmacother; 2017 Sep 02; 93():435-443. PubMed ID: 28666210
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
    Zong Z, Song Y, Xue Y, Ruan X, Liu X, Yang C, Zheng J, Cao S, Li Z, Liu Y.
    J Cell Mol Med; 2019 Aug 02; 23(8):5048-5062. PubMed ID: 31207033
    [Abstract] [Full Text] [Related]

  • 5. The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis.
    Wang F, Zhang L, Luo Y, Zhang Q, Zhang Y, Shao Y, Yuan L.
    Mol Neurobiol; 2021 Jul 02; 58(7):3362-3373. PubMed ID: 33694060
    [Abstract] [Full Text] [Related]

  • 6. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ, Ye YX, Wang YX, Du JX, Pan YH, Fang XB.
    Eur Rev Med Pharmacol Sci; 2019 Aug 02; 23(15):6612-6620. PubMed ID: 31378903
    [Abstract] [Full Text] [Related]

  • 7. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma.
    Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, Chen WJ, Sun WY, Liu XM, Chen JB.
    Cell Physiol Biochem; 2018 Aug 02; 45(5):1975-1985. PubMed ID: 29529599
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop.
    Xu L, Wu Q, Yan H, Shu C, Fan W, Tong X, Li Q.
    Cancer Lett; 2022 Jan 28; 525():33-45. PubMed ID: 34728310
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling.
    Yu H, Xu A, Wu B, Wang M, Chen Z.
    J Cell Physiol; 2021 Jan 28; 236(1):121-130. PubMed ID: 32803763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
    Yi R, Yang S, Lin X, Zhong L, Liao Y, Hu Z, Huang T, Long H, Lin J, Wu Z, Xie C, Ding S, Luo J, Luo Q, Song Y.
    J Cell Mol Med; 2020 Oct 28; 24(20):11800-11813. PubMed ID: 32902145
    [Abstract] [Full Text] [Related]

  • 14. FAM87A as a Competing Endogenous RNA of miR-424-5p Suppresses Glioma Progression by Regulating PPM1H.
    Xu H, Zhang H, Tan L, Yang Y, Wang H, Zhao Q, Lu J.
    Comput Math Methods Med; 2021 Oct 28; 2021():7952922. PubMed ID: 34712356
    [Abstract] [Full Text] [Related]

  • 15. lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway.
    Zhou XY, Liu H, Ding ZB, Xi HP, Wang GW.
    Genomics; 2020 Jan 28; 112(1):1021-1029. PubMed ID: 31226483
    [Abstract] [Full Text] [Related]

  • 16. mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt/mTOR Signaling Pathway by Targeting VEGFA.
    Liu Y, Wang Z, Tang Z, Fu Y, Wang L.
    Curr Cancer Drug Targets; 2024 Jan 28; 24(4):463-475. PubMed ID: 37592783
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of Protease Serine 8 Inhibits Glioma Cell Proliferation, Migration, and Invasion via Suppressing the Akt/mTOR Signaling Pathway.
    Yang HY, Fang DZ, Ding LS, Hui XB, Liu D.
    Oncol Res; 2017 Jul 05; 25(6):923-930. PubMed ID: 27983922
    [Abstract] [Full Text] [Related]

  • 18. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L, Liang X, Li Y.
    Oncol Rep; 2017 Oct 05; 38(4):2408-2416. PubMed ID: 28791407
    [Abstract] [Full Text] [Related]

  • 19. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
    Yang YF, Feng L, Shi Q, Wang LW, Hou LZ, Wang R, Fang JG.
    Eur Rev Med Pharmacol Sci; 2020 Aug 05; 24(16):8408-8417. PubMed ID: 32894548
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
    Wang J, Li B, Wang C, Luo Y, Zhao M, Chen P.
    J Cell Biochem; 2019 Dec 05; 120(12):19784-19795. PubMed ID: 31347720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.